6787 completed, 1157 terminated, 929 recruiting, 802 unknown. 10911 Phase 3, 1583 Phase 2.
Follow Placebo: new trials by email Literature Review of Placebo trials Research Report on Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia DA-007, Placebo - Chemotherapy Induced Alopecia, Chemotherapy Side Effects | Phase 3 | Not yet recruiting | Applied Biology, Inc. | 140 | 2027-10-10 | 2026-11-02 |
| Dantrolene in Statin-induced Myopathy Dantrolene, Placebo - Statins Induced Myopathy | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 23 | 2027-10-01 | 2025-05-13 |
| Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis Acetyl Salicylic Acid (ASA), Placebo - Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS) | Phase 3 | Not yet recruiting | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 120 | 2027-10-01 | 2026-10-30 |
| Astragalus for Symptomatic Alleviation in High-grade Lymphoma Astragalus, Placebo - High-grade Lymphoma | Phase 3 | Not yet recruiting | Bnai Zion Medical Center | 60 | 2027-08-01 | 2026-09-30 |
| Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis Gene Therapy GNSC-001, Placebo - Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis | Phase 2 / Phase 3 | Not yet recruiting | Genascence Corporation | 240 | 2027-07-01 | 2026-09-21 |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Fenix Innovation Group | 40 | 2027-07-01 | 2026-09-09 |
| Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study Tricaprilin, Placebo - Alzheimer Disease | Phase 3 | Not yet recruiting | Cerecin | 535 | 2027-07-01 | 2026-10-30 |
| Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma Sugemalimab, Placebo, Pegaspargase - Extranodal NK/T-cell Lymphoma | Phase 3 | Not yet recruiting | CStone Pharmaceuticals | 150 | 2027-06-01 | 2026-05-27 |
| Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery Moxifloxacin, Placebo - Endophthalmitis | Phase 2 / Phase 3 | Not yet recruiting | Jason Ahee, M.D. | 60000 | 2027-06-01 | 2026-09-15 |
| Fighting Osteoporosis With Risedronate Co-Therapy During Incretin Tirzepatide, Risedronate, Placebo - Obesity | Phase 3 | Not yet recruiting | Wake Forest University Health Sciences | 96 | 2027-06-01 | 2026-11-17 |
| Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age Abrocitinib, Placebo - Atopic Dermatitis | Phase 3 | Not yet recruiting | Pfizer | 90 | 2027-05-01 | 2026-09-16 |
| Semaglutide in Alcohol Use Disorder Wegovy, Placebo - Alcohol Use Disorder (AUD), Obesity | Phase 3 | Not yet recruiting | University of Minnesota | 128 | 2027-05-01 | 2026-11-19 |
| Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia | Phase 2 / Phase 3 | Not yet recruiting | UMC Utrecht | 162 | 2027-04-01 | 2026-09-21 |
| A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS) Roxadustat, Placebo - Myelodysplastic Syndromes | Phase 3 | Not yet recruiting | Kyntra Bio | 201 | 2027-04-01 | 2026-07-23 |
| Cardiovascular and Renal Protection With SGLT Inhibition in Kidney Transplant Recipients: The RENAISSANCE Trial Sotagliflozin, Placebo - Kidney Transplant Recipient | Phase 3 | Not yet recruiting | University of British Columbia | 900 | 2027-04-01 | 2026-11-18 |
| Reducing Arterial Inflammation Using Eplerenone and Statins in HIV Eplerenone, Placebo - HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD) | Phase 2 / Phase 3 | Not yet recruiting | Massachusetts General Hospital | 124 | 2027-03-01 | 2026-10-23 |
| Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma Safusidenib, Placebo - Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation, Astrocytoma IDH Mutant Grade 2 | Phase 3 | Not yet recruiting | Nuvation Bio Inc. | 140 | 2027-03-01 | 2026-07-17 |
| Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone Progesterone Injectable, Placebo, Progesterone Vaginal Suppository - Pregnancy, Progesterone Supplementation | Phase 3 | Not yet recruiting | University Hospital, Montpellier | 214 | 2027-03-01 | 2026-06-02 |
| Sotagliflozin to Lower Proteinuria in Recipients of a Kidney Transplant Sotagliflozin, Placebo - Kidney Transplant, Albuminuria | Phase 3 | Not yet recruiting | Finnian Mc Causland | 180 | 2027-03-01 | 2026-11-18 |
| A Phase 3, Multicenter Study of Vorasidenib in Combination With Temozolomide (TMZ) in Participants With IDH1- or IDH2 Mutant High-grade Astrocytoma. Vorasidenib, Placebo, Temozolomide (TMZ) - IDH-mutant High-grade Astrocytoma | Phase 3 | Not yet recruiting | Institut de Recherches Internationales Servier | 550 | 2027-03-01 | 2026-11-17 |
Showing 20 of 10911. Sign in to see all of them.
Diabetes Mellitus, Type 2 (415) · COVID-19 (323) · Obesity (247) · Pain (231) · Diabetes Mellitus (185) · Pulmonary Disease, Chronic Obstructive (177) · Depressive Disorder, Major (171) · Asthma (167) · Breast Neoplasms (156) · Depression (152) · Schizophrenia (135) · Alzheimer Disease (134) · Carcinoma, Non-Small-Cell Lung (131) · Overweight (123) · Attention Deficit Disorder with Hyperactivity (121)
Eli Lilly and Company (294) · AstraZeneca (244) · Novartis Pharmaceuticals (233) · Pfizer (193) · GlaxoSmithKline (190) · Hoffmann-La Roche (157) · Sanofi (152) · Merck Sharp & Dohme LLC (140) · Boehringer Ingelheim (138) · Takeda (129) · Amgen (122) · Bayer (111) · Janssen Research & Development, LLC (107) · Assistance Publique - Hôpitaux de Paris (96) · Novo Nordisk A/S (70)
United States (5507) · Canada (2379) · Germany (2369) · Spain (2110) · France (2088) · United Kingdom (1964) · Italy (1870) · Poland (1869) · Australia (1534) · China (1532) · Belgium (1364) · South Korea (1326) · Japan (1313) · Czechia (1232) · Netherlands (1190)
PMID 38770818, PMID 34473343, PMID 39963952, PMID 33687069, PMID 37142273, PMID 40576086, PMID 31903692, PMID 32816215, PMID 35713300, PMID 37811711, PMID 39356039, PMID 32998732, PMID 36526796, PMID 36931693, PMID 37316690, PMID 40603145, PMID 22913891, PMID 25019647, PMID 31606880, PMID 33078867, PMID 34611902, PMID 35224730, PMID 37160401, PMID 37460782, PMID 24517339, PMID 24786834, PMID 26580237, PMID 32267058, PMID 33710614, PMID 34795131, PMID 34870800, PMID 34921355, PMID 36005278, PMID 36814062, PMID 37230961, PMID 38979716, PMID 22236356, PMID 27338778, PMID 27402391, PMID 29685591, PMID 30936738, PMID 31081589, PMID 31319851, PMID 32943047, PMID 33826132, PMID 33874971, PMID 35277540, PMID 35305260, PMID 35472672, PMID 37185961
2023 (246), 2015 (146), 2017 (134), 2018 (132), 2025 (129), 2016 (124), 2014 (118), 2019 (105), 2009 (104), 2008 (101), 2005 (36), 2004 (24), U10HD021373 (9), U10HD021385 (9), U10HD027880 (8)